Interdisciplinary collaboration
Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Internal and external sources of support for both established cancer research programs and promising new ideas.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Education and professional development designed to train the next generation of cancer researchers and physicians.
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.
The collaboration will enable the development of medications to treat a type of brain cancer.